Quest Diagnostics, clinical lab database provider, completed the acquisition of Med Fusion and Clear Point, laboratory businesses. Financial terms were not disclosed. "By partnering with McKesson Specialty Health and The Network, we will make Quest's state-of-the-art genomic analysis readily available to community oncologists everywhere. We also look forward to working with BSWH, a leading health system, to deliver broad access to high quality, high-value services. This transaction will not only accelerate Quest's growth in cancer diagnostics but also holds the promise of improving care for patients with cancer in Texas and the entire United States." Steve Rusckowski, Quest Diagnostics chairman, president and CEO.